Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alfa-2a versus entecavir in HBeAg-positive chronic hepatitis B with mildly elevated ALT
ChiCTR-TRC-09000541Phase 4Completed
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Apr 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of peginterferon alfa-2a and entecavir in Chronic Hepatitis B (CHB) (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoints: HBV DNA level, HBeAg level and 1 more. Started Apr 2007; status: completed.
02
Drugs
peginterferon alfa-2aentecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TRC-09000541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000541.